Source: Reuters

Danaher: Danaher gets conditional S.Korean regulatory nod for $21 bln GE biopharma unit deal

South Korea's antitrust watchdog has approved Danaher Corp's proposed $21.4 billion acquisition of General Electric's biopharma division on condition that they sell certain assets to address monopoly concerns.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Danaher's latest SEC filings

Annual Revenue

Based on data from Danaher's latest SEC filings

Employees

Thomas P. Joyce's photo - President & CEO of Danaher

President & CEO

Thomas P. Joyce

CEO Approval Rating

69/100

Danaher is a conglomerate that operates in diagnostics, life sciences, environmental and dental industry sectors.

Danaher...
Read more